STOCK TITAN

Revvity Board Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Revvity (RVTY) Board announces a regular quarterly dividend of $0.07 per share of common stock payable on August 9, 2024, to shareholders of record as of July 19, 2024.
Il consiglio di Revvity (RVTY) annuncia un dividendo trimestrale regolare di $0,07 per azione ordinaria, pagabile il 9 agosto 2024 ai possessori di record al 19 luglio 2024.
La junta de Revvity (RVTY) anuncia un dividendo trimestral regular de $0.07 por acción común, pagadero el 9 de agosto de 2024 a los accionistas registrados el 19 de julio de 2024.
레비티(RVTY) 이사회는 2024년 7월 19일 기준 주주에게 2024년 8월 9일에 지급할 보통주당 $0.07의 정기 분기 배당을 발표했습니다.
Le conseil d'administration de Revvity (RVTY) annonce un dividende trimestriel régulier de 0,07 $ par action ordinaire, payable le 9 août 2024 aux actionnaires inscrits au 19 juillet 2024.
Der Vorstand von Revvity (RVTY) kündigt eine reguläre Quartalsdividende von $0,07 pro Stammaktie an, zahlbar am 9. August 2024 an die Aktionäre, die am 19. Juli 2024 als eingetragen gelten.
Positive
  • Revvity (RVTY) declares a quarterly dividend of $0.07 per share of common stock.
  • The dividend will be paid on August 9, 2024, to shareholders of record as of July 19, 2024.
  • This move signifies Revvity's commitment to rewarding its shareholders with regular dividends.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024.

About Revvity 
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Media Relations:

Chet Murray

(781) 462-5126

chet.murray@revvity.com

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com

Source: Revvity

FAQ

What dividend has Revvity (RVTY) announced recently?

Revvity (RVTY) has declared a regular quarterly dividend of $0.07 per share of common stock.

When will the dividend be paid to Revvity (RVTY) shareholders?

The dividend will be payable on August 9, 2024.

Who is eligible to receive the dividend declared by Revvity (RVTY)?

All shareholders of record at the close of business on July 19, 2024, will receive the dividend.

What is the ticker symbol of Revvity?

The ticker symbol of Revvity is RVTY.

How much is the quarterly dividend per share of common stock declared by Revvity (RVTY)?

The quarterly dividend declared by Revvity (RVTY) is $0.07 per share.

PKI

NYSE:PKI

PKI Rankings

PKI Latest News

PKI Stock Data

14.46B
116.15M
0.27%
86.26%
2.79%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Boston

About PKI

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.